Cardiovascular Ultrasound Equipment (Global Market)

Cardiovascular Treatment Equipment (Global Market)

Main Article: Cardiovascular Treatment Equipment (Global Market)

2024: Global Cardiovascular Ultrasound Equipment Market Size Reaches $2.82 Billion YTD

At the end of 2024, the costs of the global market for ultrasound equipment (ultrasound) of the cardiovascular system amounted to $2.82 billion. Almost a third of global spending came from the North American region. This is stated in a study by Precedence Research, the results of which Zdrav.Expert reviewed in mid-September 2025.

A significant driver of the industry is the increase in the prevalence of cardiovascular disease (CVD). According to the World Health Organization, CVDs are one of the main causes of death worldwide: about 17.9 million people die from such ailments every year. More than four in five CVD deaths occur as a result of heart attack and stroke, with a third of these deaths being premature and occurring among people under the age of 70. The leading behavioral risk factors for cardiovascular disease and stroke are unhealthy diet, low levels of physical activity, tobacco use and harmful alcohol use.

Heart disease is responsible for one in seven deaths in the U.S., according to a report by the American Heart Association. Of these, the bulk falls on coronary heart disease - 43.8%. This is followed by stroke (16.8%), hypertension (9.4%), vein disease (3.1%), etc. The observed situation contributes to the growth of the demand for ultrasound systems, which help to detect possible pathologies.

Cardiovascular diseases must be detected as early as possible so that it is possible to start correcting the pathology by advising the patient and prescribing drug therapy, WHO notes.

Technological advances have a stimulating effect on the industry. Medical device manufacturers are constantly improving the characteristics of ultrasound devices and introducing new functions, including those based on artificial intelligence. Neural networks can handle vast amounts of medical information, including medical history and research data, with high efficiency. This improves the accuracy of diagnosis and minimizes errors associated with the human factor. AI systems provide predictive analytics as well as faster decision-making.

The authors of the study segment the market into transthoracic echocardiography (an ultrasound sensor is located on the surface of the human body), transesophageal echocardiography, fetal echocardiography (ultrasound examination of the heart and vessels of the fetus during pregnancy), etc. In 2024, the first of these segments accounted for more than 55% of total revenue. The most popular are Doppler ultrasonic systems, which provided 47% of income.

Geographically, North America leads with 31% of total costs. Next comes Europe with 27%, and the Asia-Pacific region closes the top three with 22%. The contribution of Latin America was 13%, the Middle East and Africa - 7%. Globally, significant industry players are named:

• GE Healthcare;
• Koninklijke Philips;
• Siemens Healthineers;
• Hitachi Medical;
• Samsung Medison;
• Shenzhen Mindray Bio-Medical Electronics (Mindray);
• Chison Wuxi Xiangsheng Medical Technology;
• Fujifilm Sonosite.

In 2025, the market size is expected to reach $3.01 billion. Precedence Research analysts predict that in the future, the CAGR will be 6.51%. Thus, by 2034, costs may increase to $5.3 billion.^[1]

2016: Market size reaches $1.27 billion

In December 2016, the analytical company MarketsandMarkets presented a study on the global market for cardiovascular ultrasound equipment. Sales of such solutions are expected to increase, but at a low pace.

Researchers expect that in 2016, manufacturers' revenue from the sale of ultrasound devices for detecting heart and vascular diseases on a global scale will amount to $1.27 billion. In the next five years, this market will grow by an average of 5.4% annually and will reach $1.66 billion by 2021.

In 2016, the market for ultrasound equipment of the cardiovascular system will amount to $1.27 billion

Most of this equipment is purchased by hospitals, but the highest growth rates from 2016 to 2021 will be shown by the segment of solutions used in treatment or examination at home and when the patients themselves visit a medical institution (as opposed to inpatient treatment).

According to experts, the main factors that will contribute to the rise of the market in question will be the growing number of cases of cardiovascular disease, technological advances and advantages of echocardiography compared to invasive cardiac diagnostic procedures.

There are also barriers to the development of the market. These include a low payback when using such devices and a slow onset of economic effect from the introduction of new technologies, according to a study by MarketsandMarkets.^[2]

The following companies are called the largest manufacturers of ultrasound equipment for the examination of the cardiovascular system by analysts:

• GE Healthcare (USA);
• Philips Healthcare (Holland);
• Siemens Healthineers (Germany);
• Hitachi Medical Corporation (Japan);
• Toshiba Medical Systems (Japan).

Notes